Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

P300-Based Brain-Computer Interface Speller Performance Estimation with Classifier-Based Latency Estimation06:09

P300-Based Brain-Computer Interface Speller Performance Estimation with Classifier-Based Latency Estimation

931
This article presents a method for estimating same-day P300 speller Brain-Computer Interface (BCI) accuracy using a small testing dataset.
931
Distributions to Estimate Population Parameter01:26

Distributions to Estimate Population Parameter

5.0K
The accurate values of population parameters such as population proportion, population mean, and population standard deviation (or variance) are usually unknown. These are fixed values that can only be estimated from the data collected from the samples. The estimates of each of these parameters are sample proportion, the sample mean, and sample standard deviation (or variance). To obtain the values of these sample statistics, data are required that have particular distribution and central...
5.0K
Bioequivalence studies: Biowaivers01:13

Bioequivalence studies: Biowaivers

233
Body:In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
233
A Method to Study Adaptation to Left-Right Reversed Audition07:14

A Method to Study Adaptation to Left-Right Reversed Audition

6.8K
The present study proposes a protocol to investigate the adaptation to left-right reversed audition achieved only by wearable devices, using neuroimaging, which can be an effective tool for uncovering the adaptability of humans to a novel environment in the auditory...
6.8K
Important Endpoints and Proliferative Markers to Assess Small Intestinal Injury and Adaptation using a Mouse Model of Chemotherapy-Induced Mucositis07:05

Important Endpoints and Proliferative Markers to Assess Small Intestinal Injury and Adaptation using a Mouse Model of Chemotherapy-Induced Mucositis

6.5K
Here, we present a protocol to establish important endpoints and proliferative markers of small intestinal injury and compensatory hyperproliferation using a model of chemotherapy-induced mucositis. We demonstrate the detection of proliferating cells using a cell cycle specific marker and using small intestinal weight, crypt depth, and villus height as...
6.5K
Experimental Manipulation of Body Size to Estimate Morphological Scaling Relationships in Drosophila06:00

Experimental Manipulation of Body Size to Estimate Morphological Scaling Relationships in Drosophila

14.3K
Morphological scaling relationships capture and describe organismal shape. We present a method to measure morphological scaling relationships across the natural range of body sizes in fully metamorphic insects. Using a simple diet manipulation we increase the distribution of trait sizes, permitting the accurate description of how shape and size...
14.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multiplicity Adjustment Methods for a Three-Way Crossover Bioequivalence Study.

Pharmaceutical statistics·2026
Same author

Numerical Simulation of Gas Injection to Increase CH<sub>4</sub> Production on the Basis of Gas-Water Two-Phase Flow.

ACS omega·2026
Same author

Deep Dive into Generic Drug Applications to Seek Harmonization of Bioequivalence Criteria for Narrow Therapeutic Index Drugs.

Pharmaceutical research·2025
Same author

A Proposal for Alternative FDA Bioequivalence Criteria for Narrow Therapeutic Index Drug Products to Support Future Harmonization.

Pharmaceutical research·2025
Same author

Unifying Dimensions: A Linear Adaptive Mixer for Lightweight Image Super-Resolution.

IEEE transactions on image processing : a publication of the IEEE Signal Processing Society·2025
Same author

Model-based approach for two-stage group sequential or adaptive designs in bioequivalence studies using parallel and crossover designs.

Statistical methods in medical research·2025

Related Experiment Video

Updated: Jan 19, 2026

P300-Based Brain-Computer Interface Speller Performance Estimation with Classifier-Based Latency Estimation
06:09

P300-Based Brain-Computer Interface Speller Performance Estimation with Classifier-Based Latency Estimation

Published on: September 8, 2023

931

Adaptive clinical endpoint bioequivalence studies with sample size re-estimation based on a nuisance parameter.

Lin Zhu1, Wanjie Sun2

  • 1Louisiana State University Health Sciences Center , New Orleans , LA , USA.

Journal of Biopharmaceutical Statistics
|September 12, 2019
PubMed
Summary

This study introduces adaptive bioequivalence (BE) designs with sample size re-estimation for locally acting drugs. These methods improve accuracy, prevent underpowered studies, and control statistical errors for generic drug development.

Keywords:
Adaptive designbioequivalencenuisance parametersample size re-estimation

More Related Videos

A Method to Study Adaptation to Left-Right Reversed Audition
07:14

A Method to Study Adaptation to Left-Right Reversed Audition

Published on: October 29, 2018

6.8K
Important Endpoints and Proliferative Markers to Assess Small Intestinal Injury and Adaptation using a Mouse Model of Chemotherapy-Induced Mucositis
07:05

Important Endpoints and Proliferative Markers to Assess Small Intestinal Injury and Adaptation using a Mouse Model of Chemotherapy-Induced Mucositis

Published on: May 12, 2019

6.5K

Related Experiment Videos

Last Updated: Jan 19, 2026

P300-Based Brain-Computer Interface Speller Performance Estimation with Classifier-Based Latency Estimation
06:09

P300-Based Brain-Computer Interface Speller Performance Estimation with Classifier-Based Latency Estimation

Published on: September 8, 2023

931
A Method to Study Adaptation to Left-Right Reversed Audition
07:14

A Method to Study Adaptation to Left-Right Reversed Audition

Published on: October 29, 2018

6.8K
Important Endpoints and Proliferative Markers to Assess Small Intestinal Injury and Adaptation using a Mouse Model of Chemotherapy-Induced Mucositis
07:05

Important Endpoints and Proliferative Markers to Assess Small Intestinal Injury and Adaptation using a Mouse Model of Chemotherapy-Induced Mucositis

Published on: May 12, 2019

6.5K

Area of Science:

  • Pharmacokinetics and Pharmacodynamics
  • Clinical Trial Design
  • Statistical Methods in Drug Development

Background:

  • Clinical endpoint bioequivalence (BE) studies compare generic (T) and innovator (R) drugs using a three-arm trial (T, R, placebo).
  • Accurate sample size estimation is crucial for BE studies, but variance over/underestimation due to design variations and high clinical endpoint variability can lead to costly or underpowered trials.
  • Traditional fixed study designs lack flexibility in adapting to emerging data.

Purpose of the Study:

  • To propose and evaluate novel sample size re-estimation approaches for clinical endpoint bioequivalence studies.
  • To identify an optimal adaptive design that enhances sample size accuracy and study power.
  • To ensure statistical validity by controlling Type 1 error rates.

Main Methods:

  • Development of four distinct sample size re-estimation methods based on nuisance parameters.
  • Simulation studies to compare the operating characteristics of the proposed adaptive designs.
  • Evaluation of Type 1 error control for both family-wise and individual alpha levels.

Main Results:

  • The proposed adaptive design with sample size re-estimation provides more accurate sample size estimates compared to fixed designs.
  • The recommended approach effectively avoids unnecessary costs associated with overestimation and underpowered studies due to underestimation.
  • The adaptive design successfully controls the Type 1 error rate at negligible levels for superiority and equivalence tests.

Conclusions:

  • Adaptive bioequivalence study designs with sample size re-estimation offer significant advantages over traditional fixed designs.
  • These methods optimize resource allocation and ensure adequate statistical power in clinical endpoint BE studies.
  • The proposed adaptive approach maintains the integrity of statistical testing for generic drug approval.